ES2319764T3 - Composicion y su uso en el tratamiento de la perdida sensorial neuropatica. - Google Patents

Composicion y su uso en el tratamiento de la perdida sensorial neuropatica. Download PDF

Info

Publication number
ES2319764T3
ES2319764T3 ES03796465T ES03796465T ES2319764T3 ES 2319764 T3 ES2319764 T3 ES 2319764T3 ES 03796465 T ES03796465 T ES 03796465T ES 03796465 T ES03796465 T ES 03796465T ES 2319764 T3 ES2319764 T3 ES 2319764T3
Authority
ES
Spain
Prior art keywords
lidocaine
nsp
treatment
use according
patch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03796465T
Other languages
English (en)
Spanish (es)
Inventor
Bradley Stuart Galer
Arnold R. Gammaitoni
Robert D. Dworkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endo Pharmaceuticals Inc
Original Assignee
Endo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Pharmaceuticals Inc filed Critical Endo Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2319764T3 publication Critical patent/ES2319764T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES03796465T 2002-11-26 2003-11-25 Composicion y su uso en el tratamiento de la perdida sensorial neuropatica. Expired - Lifetime ES2319764T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42920802P 2002-11-26 2002-11-26
US429208P 2002-11-26

Publications (1)

Publication Number Publication Date
ES2319764T3 true ES2319764T3 (es) 2009-05-12

Family

ID=32393523

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03796465T Expired - Lifetime ES2319764T3 (es) 2002-11-26 2003-11-25 Composicion y su uso en el tratamiento de la perdida sensorial neuropatica.

Country Status (9)

Country Link
EP (1) EP1565173B1 (enExample)
JP (1) JP2006509766A (enExample)
CN (1) CN1717229A (enExample)
AT (1) ATE420633T1 (enExample)
AU (1) AU2003298710B2 (enExample)
CA (1) CA2507217C (enExample)
DE (1) DE60325885D1 (enExample)
ES (1) ES2319764T3 (enExample)
WO (1) WO2004047819A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
US7592458B2 (en) 2006-07-21 2009-09-22 Wright George E Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain
CA2732784C (en) * 2008-08-13 2018-09-18 Neuroquest Inc. Compositions comprising terpene compounds for treating negative sensory phenomena
CA2738524C (en) 2008-10-02 2013-11-26 Mylan Inc. Method for making a multilayer adhesive laminate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5993018A (ja) * 1982-11-18 1984-05-29 Sumitomo Chem Co Ltd 顔面錯感覚症治療薬
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents

Also Published As

Publication number Publication date
ATE420633T1 (de) 2009-01-15
DE60325885D1 (de) 2009-03-05
CA2507217A1 (en) 2004-06-10
AU2003298710B2 (en) 2008-02-07
WO2004047819A2 (en) 2004-06-10
EP1565173A2 (en) 2005-08-24
WO2004047819A3 (en) 2004-07-29
EP1565173B1 (en) 2009-01-14
CA2507217C (en) 2012-08-28
JP2006509766A (ja) 2006-03-23
CN1717229A (zh) 2006-01-04
AU2003298710A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
US5601838A (en) Method for treating pain associated with herpes-zoster and post-herpetic neuralgia
Achar et al. Principles of office anesthesia: part I. Infiltrative anesthesia
US5411738A (en) Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
US8137711B2 (en) Methods of treating neuropathy
ES2542847T3 (es) Formulaciones que comprenden capsaicina, un anestésico local y/o un agente antipruriginoso para el tratamiento del dolor
ES2620389T3 (es) Formulaciones tópicas de co-enzima Q10 y tratamiento de dolor, fatiga y heridas
AU645023B2 (en) Compositions and method for treating painful, inflammatory or allergic disorders
US10391074B2 (en) Topical preparation for pain relief
Crisan et al. Dermatologic surgery in children: an update on indication, anesthesia, analgesia and potential perioperative complications
AR045263A1 (es) Metodo, kit y composicion farmaceutica para tratar infecciones virales
EP1565173B1 (en) Composition and its use for treating neuropathic sensory loss
ES2484068A1 (es) Una composición farmacéutica que contiene ketamina y amitriptilina
US20050112183A1 (en) Compositions and methods for treating neuropathic sensory loss
Zimmet Hyaluronidase in the prevention of sclerotherapy‐induced extravasation necrosis: a dose‐response study
Argoff Topical treatments for pain
Zeina et al. Topical glyceryl trinitrate: a possible treatment for cutaneous leishmaniasis
Sellens et al. Accidental injection of epinephrine by a child: a unique approach to treatment
Amjad et al. Acetonide with lignocaine compared with lignocaine alone in the treatment of post herpetic neuralgia
Agarwal et al. Comparative evaluation of Myolaxin and EM LA cream for attenuation of venous cannulation pain: A prospective, randomised, double blind study
KR100262177B1 (ko) 동통 처치용 조성물, 동통 처치 방법 및 동통 경감작용 증강조성물
KR900017588A (ko) 상승효과를 나타내는 배합물 및 이의 치료제로서의 용도
Kramer et al. Overview of Local Anesthesia
US20110217359A1 (en) Pharmaceutical composition for the prophylactic or therapeutic treatment of decubiti and first degree burns and treatment method
Riad Lidocaine transdermal
Nischal et al. Local Anesthesia